SDC3 and arthritic joint disease: MSC treatments (wild type and Sdc3−/−) reduced joint swelling as a measure of joint inflammation compared to serum-free medium control at days 2 (p < 0.05) and 3 (p < 0.05) post arthritis induction (Fig. 4a).